BLLN BillionToOne, Inc.
$114.00▼ -0.06%
Healthcare
Other
After hours
$114.00▲ +0.00%
Oct 28, 4:00 PM ET
Volume 453.4K
Avg Volume (10D) 433.3K
Key Metrics & Fundamentals
Market Cap
$5.38B
P/E Ratio
181.0
Div Yield
0.00%
52W Range
61.96 - 150.44
% vs 50 MA
10.70%
% vs 200 MA
18.44%
RSI-14
61.1
MACD Histogram
+1.7200
Beta (1Y vs SPY)
1.65
Free Cash Flow
$5.09M
Gross Rev
$109.45M
Gross Profit
$77.11M
EBITDA
$10.92M
COGS
$32.34M
Operating Exp
$71.60M
Operating Income
$5.50M
EBIT
$5.50M
Pretax Income
$7.52M
Net Income
$8.05M
EPS (Diluted)
0.15
Price & Volume History
Loading chart…
Recent News

BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings Growth
Zacks · Oct 28, 2026 9:00 AM ET

BillionToOne to Participate in Two Upcoming Investor Conferences
GlobeNewswire · Oct 27, 2026 8:05 AM ET
Billiontoone Insider Sold Shares Worth $1,090,575, According to a Recent SEC Filing
MT Newswires · Oct 19, 2026 4:06 AM ET

BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire · Oct 14, 2026 8:05 AM ET
BillionToOne Insider Sold Shares Worth $2,162,950, According to a Recent SEC Filing
MT Newswires · Oct 8, 2026 3:36 AM ET

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
GlobeNewswire · Oct 7, 2026 7:00 AM ET

BillionToOne (NasdaqGS:BLLN) Stock Fair Value Edges Higher As Analysts Weigh Tech And Reimbursement Risk
Simply Wall St. · Oct 3, 2026 12:15 AM ET
BillionToOne Insider Sold Shares Worth $1,326,919, According to a Recent SEC Filing
MT Newswires · Oct 1, 2026 3:31 AM ET
Billiontoone Insider Sold Shares Worth $416,625, According to a Recent SEC Filing
MT Newswires · Sep 28, 2026 6:01 PM ET

BillionToOne (BLLN) Stock Could Be A Bargain As It Jumps 30% YTD
Simply Wall St. · Sep 23, 2026 5:19 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BLLN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.